Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data

被引:122
|
作者
Houtman, Corine J. [1 ]
Kroesbergen, Jan [1 ]
Lekkerkerker-Teunissen, Karin [2 ]
van der Hoek, Jan Peter [3 ,4 ]
机构
[1] Water Lab, NL-2003 RS Haarlem, Netherlands
[2] Dunea Dune & Water, Zoetermeer, Netherlands
[3] Delft Univ Technol, Delft, Netherlands
[4] Waternet, Amsterdam, Netherlands
关键词
Mixture toxicity; Threshold of toxicological concern; Exposure assessment; Pharmaceuticals; Drinking water; PERSONAL CARE PRODUCTS; ENDOCRINE DISRUPTING COMPOUNDS; SITE WASTE-WATER; SURFACE WATERS; EMERGING CONTAMINANTS; ESTROGENIC ACTIVITY; ENVIRONMENT; REMOVAL; DRUGS; PERFORMANCE;
D O I
10.1016/j.scitotenv.2014.07.022
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The presence of pharmaceuticals in drinking water is a topic of concern. Previous risk assessments indicate that their low concentrations are very unlikely to pose risks to human health, however often conclusions had to be based on small datasets and mixture effects were not included. The objectives of this study were to a) investigate if pharmaceuticals in surface and polder water penetrate in drinking water, b) assess the lifelong exposure of consumers to pharmaceuticals via drinking water and c) assess the possible individual and mixture health risks associated with this exposure. To fulfill these aims, a 2-year set of 4-weekly monitoring data of pharmaceuticals was used from three drinking water production plants. The 42 pharmaceuticals that were monitored were selected according to their consumption volume, earlier detection, toxicity and representation of the most relevant therapeutic classes. Lifelong exposures were calculated from concentrations and compared with therapeutic doses. Health risks were assessed by benchmarking concentrations with provisional guideline values. Combined risks of mixtures of pharmaceuticals were estimated using the concept of Concentration Addition. The lifelong exposure to pharmaceuticals via drinking water was calculated to be extremely low, i.e. a few mg, in total corresponding to <10% of the dose a patient is administered on one day. The risk of adverse health effects appeared to be negligibly low. Application of Concentration Addition confirmed this for the mixture of pharmaceuticals simultaneously present The investigated treatment plants appeared to reduce the (already negligible) risk up to 80%. The large available monitoring dataset enabled the performance of a realistic risk assessment. It showed that working with maximum instead of average concentrations may overestimate the risk considerably. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:54 / 62
页数:9
相关论文
共 50 条
  • [1] Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water
    de Jongh, Cindy M.
    Kooij, Pascal J. F.
    de Voogt, Pim
    ter Laak, Thomas L.
    SCIENCE OF THE TOTAL ENVIRONMENT, 2012, 427 : 70 - 77
  • [2] Occurrence and Human Health Risk Assessment of Pharmaceuticals and Hormones in Drinking Water Sources in the Metropolitan Area of Turin in Italy
    Papagiannaki, Dimitra
    Morgillo, Stefania
    Bocina, Gianluca
    Calza, Paola
    Binetti, Rita
    TOXICS, 2021, 9 (04)
  • [3] Assessment of Environmental Health Risk for Drinking Water Sources
    Hu, Xibang
    Xu, Zhencheng
    Wang, Junneng
    Zeng, Dong
    Han, Qiuping
    PIAGENG 2013: INTELLIGENT INFORMATION, CONTROL, AND COMMUNICATION TECHNOLOGY FOR AGRICULTURAL ENGINEERING, 2013, 8762
  • [4] Pharmaceuticals in Tap Water: Human Health Risk Assessment and Proposed Monitoring Framework in China
    Leung, Ho Wing
    Jin, Ling
    Wei, Si
    Tsui, Mirabelle Mei Po
    Zhou, Bingsheng
    Jiao, Liping
    Cheung, Pak Chuen
    Chun, Yiu Kan
    Murphy, Margaret Burkhardt
    Lam, Paul Kwan Sing
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2013, 121 (07) : 839 - 846
  • [5] Water quality health and hazard risk assessment on Drinking Water Sources
    Xue Lianqinq
    Wu Chunling
    Geng Fuming
    Wu Yifeng
    2009 3RD INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, VOLS 1-11, 2009, : 5589 - +
  • [6] Health risk assessment of drinking water contaminants in Canada: The applicability of mixture risk assessment methods
    Krishnan, K
    Paterson, J
    Williams, DT
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 26 (02) : 179 - 187
  • [7] RISK ASSESSMENT OF ANTIBIOTIC PREVALENCE IN DRINKING WATER AND ITS IMPACTS ON HUMAN HEALTH IN CHINA
    Lyu, J.
    Yang, L. S.
    Chen, Y. Y.
    Ye, B. X.
    Zhang, L.
    Wang, L.
    APPLIED ECOLOGY AND ENVIRONMENTAL RESEARCH, 2021, 19 (01): : 219 - 236
  • [8] Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
    Kumar, Arun
    Chang, Biao
    Xagoraraki, Irene
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2010, 7 (11) : 3929 - 3953
  • [9] Health risk assessment of polycyclic aromatic hydrocarbons in the source water and drinking water of China: Quantitative analysis based on published monitoring data
    Wu, Bing
    Zhang, Yan
    Zhang, Xu-Xiang
    Cheng, Shu-Pei
    SCIENCE OF THE TOTAL ENVIRONMENT, 2011, 410 : 112 - 118
  • [10] A critical review on organophosphate esters in drinking water: Analysis, occurrence, sources, and human health risk assessment
    Huang, Jianan
    Li, Jianhua
    Meng, Weikun
    Su, Guanyong
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 913